[Pathogenesis of bleeding diathesis in Weil's disease].
D000328:Adult; D000941:Antigens / Q000032:analysis; D001663:Bilirubin / Q000097:blood; D002512:Cephalothin / Q000627:therapeutic use; D003168:Complement Fixation Tests; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology; D005076:Exanthema / Q000209:etiology; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006454:Hemoglobins / Q000032:analysis; D006474:Hemorrhagic Disorders / Q000209:etiology*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007565:Jaundice / Q000209:etiology; D008297:Male; D008875:Middle Aged; D013921:Thrombocytopenia / Q000209:etiology; D014511:Uremia / Q000188:drug therapy / Q000209:etiology; D014895:Weil Disease / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000276:immunology
D000941:Antigens; D005839:Gentamicins; D006454:Hemoglobins; D006493:Heparin; D002512:Cephalothin; D001663:Bilirubin
Zur Pathogenese der Blutungsneigung beim Morbus Weil.